Member News, News

Cuatrecasas, Gonçalves Pereira Gives Fresh Impetus To New York Office And Appoints New Managing Partner

Elena Cuatrecasas moves from Barcelona office to manage the firm’s US office
Cuatrecasas, Gonçalves Pereira gives fresh impetus to its New York office, and appoints Elena Cuatrecasas as its managing partner there. The partner will move from the Barcelona office to take over from Miguel Ángel Melero, who held the position in New York between 2010 and 2014 and is now returning to the Madrid office.
Elena Cuatrecasas will promote the firm’s international expansion from a strategic position. She stated: “Combined commercial and tax experience, together with in-depth knowledge of the Iberian market, is fundamental when offering the legal service required by Spanish investments in the US and US investments in Spain and Portugal.”
The new managing partner strengthens the firm’s US team, which tax partner Íñigo Aguirrezabala joined a year ago. Together they will represent the firm from a key position, developing the commercial practice and acting as a bridge between the Iberian Peninsula, Latin America and Asia.
About the New York office

Cuatrecasas, Gonçalves Pereira opened its New York office in the heart of Manhattan in 2001. Its mission is to assist clients through its lawyers’ experience; the inclusion of legal teams of US lawyers; and knowledge of the business world and tax system in the US, as well as of the institutions and most efficient ways of doing business there.

About Elena Cuatrecasas

Elena Cuatrecasas has a Bachelor of Laws from the Universidad de Barcelona and an LL.M. from the University of London. She has extensive experience in all types of national and international corporate transactions: mergers and acquisitions, joint ventures, venture-capital transactions, leveraged buyouts (LBOs), management buyouts (MBOs), management buyins (MBIs), and group restructurings. She advises on all types of corporate and commercial contracts, and worked in the United Kingdom for two years.

She also specializes in the pharmacy, health products and biotechnology sector (life sciences), as well as the TMT sector, advising clients and investors on transactional and contractual matters.